AzTrials
AzTrials

Pediatric StrokeNCT07244042

Effects of Modified CIMT With and Without PNF

A study testing Modified CIMT and Proprioceptive Neuromuscular Facilitation in people with Pediatric Stroke, run by Riphah International University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical… Read more about this study

Who is it for?
Ages 5 to 13 years
Conditions the study is for
Pediatric Stroke
What is being tested?
Modified CIMT and Proprioceptive Neuromuscular Facilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 sitePakistan
Study dates
27 Oct 2025to 10 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Paeds Patients with confirmed diagnosis of Stroke
  • Children between age 5 to 13 years
  • Modified Ashworth Scale spasticity level 1 and 2.
  • Patients having Manual Ability Classification System Score between 3 to 6.
  • GMFCS level 1 and 2
  • Patient having in affected upper extremity at least 20◦ of active wrist extension starting from the full flexion, 10◦ of active extension or abduction in the thumb, and 10◦ of active extension in the metacarpophalangeal and interphalangeal joints of the other fingers

Who cannot join

  • Patients with epilepsy or seizure disorder
  • Patients with history of botulinum toxin injection, cognitive impairment, fracture and any surgical procedure in upper extremity

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Muhammad Asif Javed, MS-PT contact

923224209422

a.javed@riphah.edu.pk

Pakistan1 site, 1 recruiting
  • Imran Amjad

    Lahore, Punjab Province, 5400

    Muhmmad Asif Javed, MS, 033224209422, a.javed@ripah.edu.pk

    Maida Shabbir, MS*

    Recruiting

Other trials in Pakistan

About this study

Official title: Effects of Modified Constraint-induced Movement Therapy With and Without Proprioceptive Neuromuscular Facilitation Techniques on Upper Extremity Function in Pediatric Stroke Patients

This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impairments will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention

Read the detailed description

Pediatric stroke often results in impaired upper extremity function, significantly affecting children's ability to perform daily tasks and reducing their overall quality of life. Traditional therapeutic approaches may not provide sufficient recovery, necessitating the exploration of more effective interventions. Constraint-Induced Movement Therapy (CIMT) has been shown to improve motor function in pediatric stroke patients by enhancing the use of the affected limb. However, incorporating Proprioceptive Neuromuscular Facilitation (PNF) techniques may enhance the outcomes further by stimulating neuromuscular pathways to improve strength and coordination. The objective of this study is to compare the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.

This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impair-ents will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention.

Being tested
Modified CIMT, Proprioceptive Neuromuscular Facilitation
Keywords
Modified CIMT, Proprioceptive Neuromuscular Facilitation(PNF), Pediatric Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified CIMTOther

    Modified CIMT Protocol: Participants wear a mitt on the unaffected hand daily for 5 hours approximately to encourage the use of the affected upper limb. They engage in task-oriented activities designed to improve motor function, hand-eye coordination, and strength of the affected extremity.

  • Proprioceptive Neuromuscular FacilitationOther

    PNF (Proprioceptive Neuromuscular Facilitation) is a stretching and rehabilitation technique that combines muscle contraction and relaxation with passive stretching to improve flexibility, range of motion, and muscle control

Study groups in NCT07244042
Study groupRoleWhat they receive
Group A: Intervention Group (Modified CIMT+PNF)Active comparatorModified CIMT: Constraining the unaffected arm with a mitt or splint to encourage use of the affected arm (3-5 times a week). PNF Techniques: Includes rhythmic initiation, combination of isotonics, and replication exercises to enhance proprioception and motor control in the affected arm (10 reps of each technique for 15-20 minutes with rest interval) Rest Interval for 1-2 minute to prevent fatigue Routine Physiotherapy Exercises: Targeted exercises focusing on strength, range of motion, and coordination. * Strengthening: 3 sets of 10-12 reps per targeted muscle group (e.g., biceps, wrist extensors). * Range of Motion (ROM): 10-15 repetitions per joint (e.g., shoulder, elbow, wrist). * Coordination and Functional Training: Structured tasks such as reaching and grasping toys or objects for 15-20 minutes. Duration: 6 weeks
Receives: Other: Modified CIMT; Other: Proprioceptive Neuromuscular Facilitation
Group B: Control Group (Modified CIMT only)Active comparatorWarm-Up Exercises: 10-15 minutes of light exercises for the affected arm, focusing on gentle range of motion. Modified CIMT: Constraining the unaffected arm with a mitt or splint to promote use of the affected arm(3-5 times a week). Routine Physiotherapy Exercises: Targeted exercises focusing on strength, range of motion, and coordination. * Strengthening: 3 sets of 10-12 reps per targeted muscle group (e.g., biceps, wrist extensors). * Coordination and Functional Training: Structured tasks such as reaching and grasping toys or objects for 15-20 minutes. Duration: 6 week
Receives: Other: Modified CIMT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pediatric Motor Activity Log (PMAL)

    This log will be used to assess the spontaneous use of the affected upper limb in daily activities. Parents/guardians will rate the frequency and quality of use.

    Measured: Base line, 3rd Week, 6th week

  2. Modified Ashworth Scale (MAS)

    This scale will be used to assess the degree of spasticity in the affected upper limb.

    Measured: Base line, 3rd Week, 6th week

  3. Manual Ability Classification System (MACS)

    The MACS will classify the participant's ability to handle objects and perform manual tasks in daily activities.

    Measured: Base line, 3rd Week, 6th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start27 Oct 2025
  3. Primary completion25 Jan 2026 (estimated)
  4. Study completion10 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impairments will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention.
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07244042
Sponsor's protocol ID
REC/RCR&AHS/MAIDA SHABBIR
Status last verified
Nov 2025
First submitted
17 Nov 2025
Last updated
24 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Saygili F, Guclu-Gunduz A, Eldemir S, Eldemir K, Ozkul C, Gursoy GT. Effects of modified-constraint induced movement therapy based telerehabilitation on upper extremity motor functions in stroke patients. Brain Behav. 2024 Jun;14(6):e3569. doi: 10.1002/brb3.3569.

    PubMed 38873866
  • Adiguzel H, Kirmaci ZIK, Gogremis M, Kirmaci YS, Dilber C, Berktas DT. The effect of proprioceptive neuromuscular facilitation on functional skills, muscle strength, and trunk control in children with cerebral palsy: A randomized controlled trial. Early Hum Dev. 2024 May;192:106010. doi: 10.1016/j.earlhumdev.2024.106010. Epub 2024 Apr 15.

    PubMed 38653163

Questions about this trial

What is this clinical trial studying?

A study testing Modified CIMT and Proprioceptive Neuromuscular Facilitation in people with Pediatric Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact IMRAN AMJAD, PhD (9233224390125, imran.amjad@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pediatric Motor Activity Log (PMAL) (time frame: Base line, 3rd Week, 6th week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07244042, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in